Antiretroviral Drug Market is Anticipated to Increase at a Stable CAGR over the Forecast Period (2023 to 2029)
Antiretroviral drug market is anticipated to grow at a significant CAGR during the forecast period. Antiretroviral is the category of drugs that are used, act, or are effective against retroviruses particularly to treat HIV. The major driving factors contributing to the market growth include the rising prevalence and burden of HIV, growing investment in R&D related to these drugs coupled with the rise in the availability of novel drugs that pose better efficacy than ever before. These drugs are available in several categories that majorly include Integrase Inhibitors, Protease Inhibitors, Multi-class Combination Products, Nucleoside Reverse Transcriptase Inhibitors (NRTIs), Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) and others.
According to the US Department
of Health & Human Services, in the year 2018, there were nearly 37.9
million people globally living with HIV/AIDS. An estimated 1.7 million
individuals globally became newly infected with HIV in 2018. Currently,
antiretrovirals are considered to be the basis of HIV/AIDS treatment, since
there is no solid cure or a preventive vaccine available for HIV. In the case
of a non-resistant strain of HIV, antiretroviral treatment can restrain the
replication of HIV in the majority of cases. Thus, the presence of a huge
patient pool demands anti-retroviral drugs for the treatment which is projected
to drive the growth of the market during the forecast period.
Some key players operating in the market include AbbVie Inc., Boehringer
Ingelheim, Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd, Gilead Sciences,
among others. These players are aiming to strengthen their position in the market
by adopting various strategies as mergers and acquisitions, partnerships,
collaborations, new product launches and development in the existing product
portfolio, and so on.
To Request a Sample of our Report on Antiretroviral Drug
Market: https://www.omrglobal.com/request-sample/antiretroviral-drug-market
Market Coverage
·
The market number available for – 2021-2029
·
Base year- 2021
·
Forecast period- 2023-2029
·
Segment Covered
·
Regions Covered- Globally
·
Competitive Landscape: AbbVie Inc., Boehringer Ingelheim,
Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd, Gilead Sciences, among
others.
Antiretroviral Drug Market by Segments
By Drug Class
• Integrase Inhibitors
• Protease Inhibitors
• Multi-class Combination
Products
• Nucleoside Reverse
Transcriptase Inhibitors
• Non-Nucleoside Reverse
Transcriptase Inhibitors
• Others
A
full Report of Antiretroviral Drug Market is Available at: https://www.omrglobal.com/industry-reports/antiretroviral-drug-market
Antiretroviral Drug Market by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment